Precision medicine


There are approximately 60 000 individuals diagnosed with cancer (new cases) per year in Sweden, and approximately 12 million world-wide.

BioReperia have in collaboration with clinicians demonstrated that our unique platform enable identification of efficacious anti-cancer therapies customized to the individual cancer patient´s need within 5 days. This will allow patients to receive the most efficacious treatment available, thus improving prognosis and reducing costs related to failed treatments.

Currently we are conducting a clinical trial together with surgeons from Region Östergötland and researchers at Linköping University to further validate and improve our model.